Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases.
- DOI
- 10.1021/acschembio.6c00369
- Published
- 2026-08-17
- Container
- ACS Chem Biol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acschembio.6c00369,
title = {Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases.},
author = {Singh V and Wan Y and Gao Z and Ahmed TR and Wang SY and Chen K and Kumar Samrat S and Li Z and Sinha S and Gan L and Li H.},
year = {2026},
journal = {ACS Chem Biol},
doi = {10.1021/acschembio.6c00369},
url = {https://doi.org/10.1021/acschembio.6c00369}
}RIS
TY - JOUR TI - Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases. AU - Singh V AU - Wan Y AU - Gao Z AU - Ahmed TR AU - Wang SY AU - Chen K AU - Kumar Samrat S AU - Li Z AU - Sinha S AU - Gan L AU - Li H. PY - 2026 JO - ACS Chem Biol DO - 10.1021/acschembio.6c00369 UR - https://doi.org/10.1021/acschembio.6c00369 ER -
APA
V, S., Y, W., Z, G., TR, A., SY, W., K, C., S, K. S., Z, L., S, S., L, G., & H., L. (2026). Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases.. ACS Chem Biol. https://doi.org/10.1021/acschembio.6c00369
Source records
- europe-pmc · retrieved 2026-09-25T19:57:22.895Z